Peter Ackerman
Impact in
- Virology top 5%
- HIV Research and Treatment
- Hepatology top 5%
- Hepatitis C virus research
Papers in
-
- HIV/AIDS drug development and treatment 14
- HIV/AIDS Research and Interventions 9
- Virology 13
- HIV Research and Treatment 13
- Co-authors
- Cyril Llamoso (13 shared papers)Mindy Magee (9 shared papers)Max Lataillade (8 shared papers)Anne F. Luetkemeyer (3 shared papers)Stephanie Noviello (4 shared papers)Margaret Gartland (4 shared papers)Amy Pierce (6 shared papers)Silke Frahm (1 shared paper)
- Journals
- Open Forum Infectious Diseases (5 papers)Journal of Antimicrobial Chemotherapy (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)AIDS (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Peter Ackerman
29 papers receiving 526 citations
Peers
Comparison fields: 5 of 56
- Virology 136
- Hepatology 122
- Infectious Diseases 196
- Neurology 122
- Epidemiology 128
Countries citing papers authored by Peter Ackerman
This map shows the geographic impact of Peter Ackerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ackerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ackerman more than expected).
Fields of papers citing papers by Peter Ackerman
This network shows the impact of papers produced by Peter Ackerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ackerman. The network helps show where Peter Ackerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Ackerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 160 | |
| 2 | 2020 | 103 | |
| 3 | 2015 | 55 | |
| 4 | 2016 | 45 | |
| 5 | 2015 | 19 | |
| 6 | 2020 | 17 | |
| 7 | 2021 | 14 | |
| 8 | 2020 | 12 | |
| 9 | 2019 | 11 | |
| 10 | 2022 | 11 | |
| 11 | 2019 | 11 | |
| 12 | 2021 | 10 | |
| 13 | 2016 | 10 | |
| 14 | 2017 | 8 | |
| 15 | 2022 | 8 | |
| 16 | Monitored viral load: a measure of HIV treatment outcomes in an outpatient setting in Rhode Island. | 2014 | 7 |
| 17 | 2020 | 7 | |
| 18 | 2022 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2021 | 3 |
About Peter Ackerman
Peter Ackerman is a scholar working on Infectious Diseases, Virology, Hepatology, Epidemiology and Emergency Medicine, having authored 30 papers that have together received 535 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (13 papers), HIV/AIDS Research and Interventions (9 papers), Hepatitis C virus research (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Sarcoma Diagnosis and Treatment (1 paper), Pharmacogenetics and Drug Metabolism (1 paper) and Simulation-Based Education in Healthcare (1 paper). The work is most often cited by research in Virology (136 citations), Hepatology (122 citations), Infectious Diseases (196 citations), Neurology (122 citations) and Epidemiology (128 citations). Peter Ackerman has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Cyril Llamoso, Mindy Magee, Max Lataillade, Anne F. Luetkemeyer, Stephanie Noviello, Margaret Gartland, Amy Pierce, Silke Frahm, Nancy Ratner and Arie Perry. Their work appears in journals such as Open Forum Infectious Diseases, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, AIDS and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.